Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 652 K674 K849 K1.39 M 3.57 M Research & development 600 K300 K600 K— — Operating income -7.08 M-10.12 M-9.12 M-12.04 M -38.36 M Non-Operating Income, Total 0-138 K95 K-2 000 -45 K Interest expense, net of interest capitalized ———— — Non-Operating Income, excl. Interest Expenses 0-10 K-1 000-2 000 -13 K Unusual income/expense 0-128 K96 K— — Pretax income -7.39 M-10.82 M-11.37 M-19.34 M -48.91 M Equity in earnings ———— — Taxes 000-3.99 M -3.99 M Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations -7.39 M-10.82 M-11.37 M-19.34 M -48.91 M Discontinued operations ———— — Net income -7.39 M-10.82 M-11.37 M-19.34 M -48.91 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders -7.39 M-10.82 M-11.37 M-19.34 M -48.91 M Basic earnings per share (Basic EPS) -0.04-0.06-0.06-0.09 -0.25 Diluted earnings per share (Diluted EPS) -0.04-0.06-0.06-0.09 -0.25 Average basic shares outstanding 172.97 M183.56 M195.5 M194.35 M — Diluted shares outstanding 172.97 M183.56 M195.5 M194.35 M — EBITDA -6.85 M-9.89 M-8.85 M-11.65 M -37.24 M EBIT -7.08 M-10.12 M-9.12 M-12.04 M -38.36 M Cost of revenue 1.21 M1.8 M1.27 M5.38 M 9.66 M Other cost of goods sold ———— — Depreciation & amortization (cash flow) 228 K236 K267 K396 K 1.13 M